Literature DB >> 2507834

Amiodarone-induced pulmonary toxicity in the rat.

B D Wilson1, A J Jaworski, M E Donner, M L Lippmann.   

Abstract

A rat model of amiodarone-induced pulmonary toxicity is described. The rats were fed, by gavage, 175 mg/kg/day of amiodarone hydrochloride suspended in methyl cellulose. Controls received methyl cellulose alone. Groups of rats were examined after 1, 3, 6, 9, and 12 weeks of feeding. We found that drug-fed rats had significantly more macrophages, neutrophils, and lymphocytes in the bronchoalveolar lavage (BAL). The early increase in cellularity was due to an increase in macrophages, and the macrophage count peaked after 6 weeks of drug treatment. The number of neutrophils in the experimental animals remained high throughout the course of the experiment. An increasing number of lymphocytes was seen in the BAL between 6 and 12 weeks of drug treatment. Protein in the lavage fluid was significantly elevated after 12 weeks of amiodarone exposure. Histologic sections were abnormal after 3 weeks of drug treatment, characterized by interstitial thickening with accumulation of mononuclear cells and alveoli packed with large foamy macrophages. There was only minimal evidence of fibrosis. This model appears to be very similar to human amiodarone-induced pulmonary toxicity and should be useful for the study of the pathogenesis of amiodarone-induced toxicity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507834     DOI: 10.1007/bf02714959

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  29 in total

1.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.

Authors:  J F WOESSNER
Journal:  Arch Biochem Biophys       Date:  1961-05       Impact factor: 4.013

2.  Re: Speculation on the mechanism for amiodarone-induced pneumonitis.

Authors:  P Camus; L Jeannin
Journal:  Radiology       Date:  1984-01       Impact factor: 11.105

Review 3.  Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.

Authors:  F I Marcus; G H Fontaine; R Frank; Y Grosgogeat
Journal:  Am Heart J       Date:  1981-04       Impact factor: 4.749

4.  In vitro inhibition of lysosomal phospholipase A1 of rat lung by amiodarone and desethylamiodarone.

Authors:  K Y Hostetler; J R Giordano; E J Jellison
Journal:  Biochim Biophys Acta       Date:  1988-04-15

5.  Amiodarone-induced pulmonary fibrosis in hamsters.

Authors:  J O Cantor; M Osman; J M Cerreta; R Suarez; I Mandl; G M Turino
Journal:  Exp Lung Res       Date:  1984       Impact factor: 2.459

6.  Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats.

Authors:  K Y Hostetler; M J Reasor; E R Walker; P J Yazaki; B W Frazee
Journal:  Biochim Biophys Acta       Date:  1986-02-12

7.  Bronchoalveolar lavage in amiodarone pneumonitis. Cellular abnormalities and their relevance to pathogenesis.

Authors:  D Israël-Biet; A Venet; I Caubarrère; G Bonan; C Danel; J Chrétien; A J Hance
Journal:  Chest       Date:  1987-02       Impact factor: 9.410

8.  Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug.

Authors:  W J Martin; D M Howard
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

9.  Prospective evaluation of amiodarone pulmonary toxicity.

Authors:  P J Kudenchuk; D J Pierson; H L Greene; E L Graham; G K Sears; G B Trobaugh
Journal:  Chest       Date:  1984-10       Impact factor: 9.410

10.  Amiodarone lung toxicity: a human and experimental study.

Authors:  F R Costa-Jussà; B Corrin; J M Jacobs
Journal:  J Pathol       Date:  1984-10       Impact factor: 7.996

View more
  6 in total

1.  Susceptibility to amiodarone-induced pulmonary toxicity: relationship to the uptake of amiodarone by isolated lung cells.

Authors:  B D Wilson; M L Lippmann
Journal:  Lung       Date:  1996       Impact factor: 2.584

Review 2.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

3.  Acute pulmonary inflammation in hamsters following intratracheal administration of amiodarone.

Authors:  T L Blake; M J Reasor
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

4.  Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats.

Authors:  Durairaj Punithavathi; Narayanan Venkatesan; Mary Babu
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

5.  Amiodarone--induced changes in surfactant phospholipids of rat lung.

Authors:  B Padmavathy; H Devaraj; N Devaraj
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-04       Impact factor: 3.000

6.  Amiodarone causes decreased cell-mediated immune responses and inhibits the phospholipase C signaling pathway.

Authors:  B D Wilson; C E Clarkson; M L Lippmann
Journal:  Lung       Date:  1993       Impact factor: 2.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.